Skip to main content
SpringerLink
Log in

The Economic Potential of Tamoxifen Prophylaxis in Breast Cancer

  • Current Opinion
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Early Breast Cancer Trialists’ Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: part 1. Lancet 1992; 339(8784): 1–15

    Google Scholar 

  2. Early Breast Cancer Trialists’ Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: part 2. Lancet 1992; 339(8785): 71–85

    Google Scholar 

  3. Plowman PN. Tamoxifen as adjuvant therapy in breast cancer: current status. Drugs 1993; 46(5): 819–33

    Article  PubMed  CAS  Google Scholar 

  4. Glasziou P, Haas M. An economic evaluation of the use of tamoxifen in the treatment of early breast cancer [unpublished]. Sydney: Centre for Health Economics Research and Evaluation, Westmead Hospital; 1994. Discussion paper no.: 25

    Google Scholar 

  5. Corry JF, Lønning PE. Systemic therapy in breast cancer: efficacy and cost-utility. Pharmacoeconomics 1994; 5(3): 198–212

    Article  PubMed  CAS  Google Scholar 

  6. Love RR. Tamoxifen prophylaxis in breast cancer. Oncology 1992; 6(7): 33–8

    PubMed  CAS  Google Scholar 

  7. Meyskens PL, Atiba JO. The Love article reviewed. Oncology 1992; 6(7): 38–9

    Google Scholar 

  8. Spicer DV, Henderson BE. The Love article reviewed. Oncology 1992; 6(7): 40–3

    Google Scholar 

  9. Bush TL, Helzlsouer KJ. Tamoxifen for the primary prevention of breast cancer: a review and critique of the concept and trial. Epidemiol Rev 1993; 15(1): 223–43

    Google Scholar 

  10. Chlebowski RT, Butler J, Nelson A, et al. Tamoxifen: current issues and future prospective. Cancer 1993; 72 (3 Suppl.): 1032–7

    Article  PubMed  CAS  Google Scholar 

  11. Ganz PA, Day R, Ware JE, et al. Base-line quality-of-life assessment in the National Surgical Adjuvant Breast and Bowel Project Breast Cancer Prevention Trial. J Natl Cancer Inst 1995; 87(18): 1372–82

    Article  PubMed  CAS  Google Scholar 

  12. Powles TJ, Tillyer CR, Jones AL. Prevention of breast cancer with tamoxifen: an update on the Royal Marsden Hospital Pilot Programme. Eur J Cancer 1990; 26(6): 680–4

    Article  PubMed  CAS  Google Scholar 

  13. Costa A. Breast cancer chemoprevention. Eur J Cancer 1993; 29A(4): 589–92

    Article  PubMed  CAS  Google Scholar 

  14. Costa A. Tamoxifen trial in healthy women at risk of breast cancer [letter]. Lancet 1993; 342: 444

    Article  PubMed  CAS  Google Scholar 

  15. Nease RF, Ross JM. The decision to enter a randomized trial of tamoxifen for the prevention of breast cancer in healthy women: an analysis of the tradeoffs. Am J Med 1995; 99: 180–89

    Article  PubMed  Google Scholar 

  16. Love RR, Cameron L, Connell BL, et al. Symptoms associated with tamoxifen treatment in postmenopausal women. Arch Intern Med 1991; 151(9): 1842–7

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. National Centre for Epidemiology and Population Health, The Australian National University, Canberra, ACT, 0200, Australia

    James R. G. Butler

Authors
  1. James R. G. Butler
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to James R. G. Butler.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Butler, J.R.G. The Economic Potential of Tamoxifen Prophylaxis in Breast Cancer. Pharmacoeconomics 12, 303–306 (1997). https://doi.org/10.2165/00019053-199712030-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00019053-199712030-00002

Search

Navigation